Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018
This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2018-06-12 | Calendars | Placed on the Union Calendar, Calendar No. 575. | House floor actions |
| 2018-06-12 | Discharge | Committee on Ways and Means discharged. | House floor actions |
| 2018-06-12 | Committee | Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I. | House floor actions |
| 2018-05-16 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2018-05-09 | Committee | Ordered to be Reported by Voice Vote. | House committee actions |
| 2018-05-09 | Committee | Committee Consideration and Mark-up Session Held. | House committee actions |
| 2018-05-07 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2018-05-07 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2018-05-07 | IntroReferral | Introduced in House | Library of Congress |